PGEN

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue ————23.25 M — Gross profit ————23.25 M — Operating expenses -4.82 M5.88 M8.61 M7.34 M29.25 M 51.08 M Selling/general/admin expenses 2.68 M1.64 M4.39 M2.16 M21.05 M 29.24 M Research & development ————5.64 M — Operating income 4.82 M-5.88 M-8.61 M-7.34 M-5.99 M -27.83 M Non-Operating Income, Total ————-1.94 M — Interest expense, net of interest capitalized ————2.91 M — Non-Operating Income, excl. Interest Expenses ————-2.23 M — Unusual income/expense ————290 K — Pretax income 4.82 M-5.88 M-8.61 M-250.64 M-7.93 M -273.06 M Equity in earnings ————— — Taxes 03 000000 3 000 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -54.15 M-26.64 M-146.34 M-23.5 M-7.93 M -204.42 M Discontinued operations ———0— — Net income -54.15 M-26.64 M-146.34 M-23.5 M-7.93 M -204.42 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -54.15 M-26.64 M-325.34 M-23.5 M-7.93 M -383.42 M Basic earnings per share (Basic EPS) -0.18-0.09-1.06-0.04-0.02 -1.21 Diluted earnings per share (Diluted EPS) -0.18-0.09-1.06-0.04-0.02 -1.21 Average basic shares outstanding 293.88 M296.43 M307.17 M312.98 M354.29 M — Diluted shares outstanding 293.88 M296.43 M307.17 M312.98 M354.29 M — EBITDA ————-4.89 M — EBIT ————-5.99 M — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 629 K630 K803 K1.14 M1.1 M 3.67 M